Quark Pharmaceuticals Income Statement
View: Annual
| Dec 06 | Dec 05 | Dec 04 | |
|---|---|---|---|
| Revenue | 4.3 | 3.4 | 4.9 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 21.9 | 11.3 | 21.4 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (17.6) | (7.8) | (16.5) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.7 | 0.4 | 0.3 |
| Nonoperating Expenses | 0.0 | 0.0 | 0.0 |
| Income Before Taxes | (17.0) | (7.5) | (16.2) |
| Income Taxes | 0.0 | 0.0 | 0.0 |
| Net Income After Taxes | (17.0) | (7.5) | (16.2) |
| Continuing Operations | (17.0) | (7.5) | (16.2) |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | (17.0) | (7.5) | (16.2) |
| Total Net Income | (17.0) | (7.5) | (16.2) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
